DIABETES OBESITY & METABOLISM

Scope & Guideline

Connecting researchers to enhance patient care in endocrinology.

Introduction

Welcome to your portal for understanding DIABETES OBESITY & METABOLISM, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1462-8902
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1999 to 2024
AbbreviationDIABETES OBES METAB / Diabetes Obes. Metab.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Diabetes Obesity & Metabolism' serves as a key platform for advancing research in the fields of diabetes, obesity, and related metabolic disorders. Its primary focus is on the interplay between these conditions and their impact on health outcomes, providing a comprehensive overview of current advancements in clinical and translational research.
  1. Diabetes Management and Treatment Approaches:
    The journal publishes studies examining various treatment modalities for diabetes, including pharmacological interventions, lifestyle changes, and technology-assisted management, such as continuous glucose monitoring and insulin delivery systems.
  2. Obesity and Metabolic Disorders:
    Research on obesity, its pathophysiology, and its relationship with metabolic disorders is a core area of focus, encompassing interventions that target weight management and metabolic health.
  3. Cardiovascular and Renal Outcomes:
    The journal emphasizes the importance of cardiovascular and renal health in patients with diabetes and obesity, highlighting studies that investigate the impact of glucose-lowering therapies on these outcomes.
  4. Epidemiology and Public Health:
    Epidemiological studies that assess the prevalence, risk factors, and socio-economic implications of diabetes and obesity are integral to the journal's scope, providing insights into public health strategies.
  5. Innovations in Diabetes Technology:
    The journal explores advancements in diabetes technology, including artificial pancreas systems, telehealth solutions, and digital health applications that enhance diabetes management and patient outcomes.
  6. Mechanisms of Disease:
    Research elucidating the biological mechanisms underlying diabetes, obesity, and their complications is a significant aspect of the journal, contributing to a deeper understanding of disease pathology.
The journal has increasingly highlighted innovative and interdisciplinary approaches to diabetes and obesity research, reflecting current trends and emerging themes within the field. These developments are crucial for addressing the multifaceted challenges posed by these conditions.
  1. Integrated Care Models:
    There is a rising emphasis on research that examines integrated care models for diabetes management, which combine medical treatment, lifestyle modifications, and digital health tools to improve patient outcomes.
  2. Impact of Technology on Diabetes Management:
    Emerging studies focus on the role of technology, including artificial intelligence and telehealth, in enhancing diabetes care and patient engagement.
  3. Long-Term Complications and Comorbidities:
    Research exploring the long-term complications of diabetes, particularly in relation to cardiovascular and renal health, is gaining traction, emphasizing the need for comprehensive management strategies.
  4. Mental Health and Diabetes:
    There is an increasing recognition of the mental health aspects of diabetes management, with studies investigating the psychological impact of diabetes and obesity on patients and the effectiveness of interventions.
  5. Precision Medicine Approaches:
    The journal is seeing a trend towards precision medicine, with studies focusing on personalized treatment strategies based on genetic, phenotypic, and lifestyle factors.
  6. Microbiome and Metabolism:
    Research investigating the gut microbiome's role in metabolism and its implications for diabetes and obesity is emerging, highlighting the intersection of metabolic and microbiological health.

Declining or Waning

While 'Diabetes Obesity & Metabolism' has consistently focused on critical areas of diabetes and obesity research, some themes have shown a decline in prominence over recent years. This may reflect shifts in research priorities and emerging interests within the scientific community.
  1. Traditional Diet-Based Interventions:
    Research focusing solely on traditional dietary interventions for diabetes management appears to be less prevalent, as newer studies explore more integrated approaches that combine pharmacological and lifestyle interventions.
  2. Basic Science Studies:
    There is a noticeable decrease in the publication of basic science studies that do not directly translate to clinical applications, as the journal increasingly prioritizes translational and clinical research.
  3. Pharmacological Comparisons:
    Studies comparing older diabetes medications, such as sulfonylureas, to newer agents have decreased, as the focus shifts toward more innovative therapies such as GLP-1 receptor agonists and SGLT2 inhibitors.
  4. Single-Cohort Studies:
    The prevalence of single-cohort studies has waned, with a growing preference for multi-center trials and large-scale epidemiological studies that offer broader insights into diabetes and obesity management.

Similar Journals

Diabetes Epidemiology and Management

Exploring Solutions, Shaping Diabetes Management
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Diabetes Epidemiology and Management, published by Elsevier, is an innovative open-access journal that has been addressing the critical issues surrounding diabetes since its inception in 2021. This journal integrates a comprehensive exploration of the epidemiology, prevention, and management of diabetes, making it a pivotal resource within the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine. With a digital presence represented by E-ISSN 2666-9706, it currently holds a commendable position in the academic landscape, categorized in the Q3 quartile for both Endocrinology and Internal Medicine as per the 2023 metrics. The journal aims to enhance understanding and promote research on diabetes, offering authors a platform to share their findings with a global audience. Researchers, professionals, and students alike can benefit from this essential resource, which is dedicated to advancing the knowledge base and improving clinical practices in diabetes management. With open access options since 2021, the journal ensures that vital research is widely accessible, driving innovation and collaboration in the fight against diabetes.

ACTA DIABETOLOGICA

Connecting Innovators in Endocrinology
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0940-5429Frequency: 12 issues/year

ACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.

Journal of Diabetes Investigation

Advancing diabetes research for a healthier tomorrow.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

Therapeutic Advances in Endocrinology and Metabolism

Fostering collaboration for groundbreaking endocrine research.
Publisher: SAGE PUBLICATIONS LTDISSN: 2042-0188Frequency: 1 issue/year

Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Elevating Standards in Diabetes and Metabolic Research
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

British Journal of Diabetes

Illuminating the path to better diabetes outcomes.
Publisher: ASSOC BRITISH CLINICAL DIABETOLOGISTSISSN: 2397-6233Frequency: 2 issues/year

The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.

DIABETES-METABOLISM RESEARCH AND REVIEWS

Advancing the Science of Diabetes and Metabolism
Publisher: WILEYISSN: 1520-7552Frequency: 8 issues/year

DIABETES-METABOLISM RESEARCH AND REVIEWS, published by WILEY, is an esteemed academic journal focusing on the forefront of research in the fields of endocrinology, diabetes, and metabolism. Since its inception in 1999, this journal has become a crucial resource for researchers, professionals, and students, boasting an impressive impact factor that reflects its high citation rates and contribution to the field. With a 2023 classification of Q1 in several categories including Endocrinology and Internal Medicine, it ranks among the top journals globally, demonstrating its significant influence and authority. The journal serves as a platform for the dissemination of innovative research, reviews, and methodologies that advance understanding and treatment of metabolic disorders. By offering valuable insights and fostering collaboration within the scientific community, DIABETES-METABOLISM RESEARCH AND REVIEWS is essential reading for anyone involved in diabetes research and clinical practice.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Innovating insights for endocrine health.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

Diabetes & Metabolism Journal

Transforming diabetes research into actionable insights.
Publisher: KOREAN DIABETES ASSOCISSN: 2233-6079Frequency: 6 issues/year

Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.

Cardiovascular Endocrinology & Metabolism

Exploring the Nexus of Metabolism and Heart Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2574-0954Frequency: 4 issues/year

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.